Origin and Epidemiological History of HIV-1 CRF14_BG

2010, UNAIDS report on the global AIDS epidemic 2010.

2009, Infecção VIH/SIDA, A situação em Portugal a 31 de Dezembro de 2008

AC Palma, 2007, Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal., Infect Genet Evol, 7, 391, 10.1016/j.meegid.2007.01.009

A Esteves, 2002, Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes., AIDS Res Hum Retroviruses, 18, 313, 10.1089/088922202753519089

V Duque, 2003, Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal., Clin Microbiol Infect, 9, 422, 10.1046/j.1469-0691.2003.00541.x

A Esteves, 2003, Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal., AIDS Res Hum Retroviruses, 19, 511, 10.1089/088922203766774568

FM Araujo, 2004, Detection of HIV-1 subtype G using Cobas Ampliscreen test., J Clin Virol, 30, 205, 10.1016/j.jcv.2003.11.001

R Antunes, 2003, Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms., J Clin Microbiol, 41, 3361, 10.1128/JCM.41.7.3361-3367.2003

AB Abecasis, 2011, Molecular Epidemiological Analysis of Paired pol/env Sequences from Portuguese HIV Type 1 Patients., AIDS Res Hum Retroviruses, 27, 803, 10.1089/aid.2010.0312

E Delgado, 2002, Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure., J Acquir Immune Defic Syndr, 29, 536, 10.1097/00126334-200204150-00016

B Harris, 2005, Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany., AIDS Res Hum Retroviruses, 21, 654, 10.1089/aid.2005.21.654

M Adojaan, 2005, Predominance of a rare type of HIV-1 in Estonia., J Acquir Immune Defic Syndr, 39, 598

S Menzo, 2004, Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment., Antimicrob Agents Chemother, 48, 3253, 10.1128/AAC.48.9.3253-3259.2004

L Xu, 2005, Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41., Antimicrob Agents Chemother, 49, 1113, 10.1128/AAC.49.3.1113-1119.2005

R Parreira, 2005, Genetic analysis of human immunodeficiency virus type 1 nef in Portugal: subtyping, identification of mosaic genes, and amino acid sequence variability., J Med Virol, 77, 8, 10.1002/jmv.20408

C de Mendoza, 2005, Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain., Clin Infect Dis, 41, 1350, 10.1086/496982

A Holguin, 2005, Heterogeneous nature of HIV-1 recombinants spreading in Spain., J Med Virol, 75, 374, 10.1002/jmv.20280

A Holguin, 2008, Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain., Curr HIV Res, 6, 327, 10.2174/157016208785132455

E Lospitao, 2005, HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003., HIV Med, 6, 313, 10.1111/j.1468-1293.2005.00313.x

L Perez-Alvarez, 2002, Biological characteristics of newly described HIV-1 BG recombinants in Spanish individuals., AIDS, 16, 669, 10.1097/00002030-200203080-00021

L Perez-Alvarez, 2006, Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain., J Med Virol, 78, 1520, 10.1002/jmv.20734

JD Thompson, 1997, The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools., Nucleic Acids Res, 25, 4876, 10.1093/nar/25.24.4876

MT Cuevas, 2010, Short communication: Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment., AIDS Res Hum Retroviruses, 26, 1019, 10.1089/aid.2010.0018

I Bartolo, 2009, Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man., AIDS, 23, 2359, 10.1097/QAD.0b013e328332d5e1

JJ De Jong, 1992, Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution., J Virol, 66, 6777, 10.1128/JVI.66.11.6777-6780.1992

W Resch, 2001, Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks., Virology, 288, 51, 10.1006/viro.2001.1087

L Perez, 2006, HIV Type 1 molecular epidemiology in cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms., AIDS Res Hum Retroviruses, 22, 724, 10.1089/aid.2006.22.724

ES Daar, 2007, Baseline HIV type 1 coreceptor tropism predicts disease progression., Clin Infect Dis, 45, 643, 10.1086/520650

S Raymond, 2010, CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression., Aids, 24, 2305, 10.1097/QAD.0b013e32833e50bb

MB Goetz, 2009, Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection., J Acquir Immune Defic Syndr, 50, 259, 10.1097/QAI.0b013e3181989a8b

DR Kuritzkes, 2008, HIV-1 subtype as a determinant of disease progression., J Infect Dis, 197, 638, 10.1086/527417

N Sacktor, 2009, HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda., Clin Infect Dis, 49, 780, 10.1086/605284

SD Frost, 2005, Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection., Proc Natl Acad Sci U S A, 102, 18514, 10.1073/pnas.0504658102

PL Moore, 2009, Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection., PLoS Pathog, 5, e1000598, 10.1371/journal.ppat.1000598

A McKnight, 1995, Immune escape and tropism of HIV., Trends Microbiol, 3, 356, 10.1016/S0966-842X(00)88975-1

A McKnight, 1995, Change in tropism upon immune escape by human immunodeficiency virus., J Virol, 69, 3167, 10.1128/JVI.69.5.3167-3170.1995

J Marcelino, 2010, Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a Vaccinia virus vector-prime C2V3C3 polypeptide-boost immunization strategy., J Virol

T Leitner, 1995, Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden., Virology, 209, 136, 10.1006/viro.1995.1237

GS Sandhu, 1995, Molecular probes for diagnosis of fungal infections., J Clin Microbiol, 33, 2913, 10.1128/JCM.33.11.2913-2919.1995

JK Carr, 1996, Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand., J Virol, 70, 5935, 10.1128/JVI.70.9.5935-5943.1996

KB Nicholas, 1997, GeneDoc: a tool for editing and annotating multiple sequence alignments., Distributed by the author

KS Lole, 1999, Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination., J Virol, 73, 152, 10.1128/JVI.73.1.152-160.1999

J Felsenstein, 1981, Evolutionary trees from DNA sequences: a maximum likelihood approach., J Mol Evol, 17, 368, 10.1007/BF01734359

D Posada, 1998, MODELTEST: testing the model of DNA substitution., Bioinformatics, 14, 817, 10.1093/bioinformatics/14.9.817

AJ Drummond, 2007, BEAST: Bayesian evolutionary analysis by sampling trees., BMC Evol Biol, 7, 214, 10.1186/1471-2148-7-214

AB Abecasis, 2009, Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution., J Virol, 83, 12917, 10.1128/JVI.01022-09

B Korber, 2000, Timing the ancestor of the HIV-1 pandemic strains., Science, 288, 1789, 10.1126/science.288.5472.1789

P Borrego, 2008, The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients., Retrovirology, 5, 78, 10.1186/1742-4690-5-78

T Sing, 2007, Predicting HIV coreceptor usage on the basis of genetic and clinical covariates., Antivir Ther, 12, 1097, 10.1177/135965350701200709